Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit
AUTOR(ES)
Hunter, Richard
RESUMO
Paired cerebrospinal fluid (CSF) and serum samples collected from 81 of 241 patients admitted to a district psychiatric hospital during a six month period were assayed for fibrin/fibrinogen degradation products (FDP) using a haemagglutination inhibition technique. FDP were found in all serum samples. Fifteen patients (18·5%) had FDP in the CSF (range 0·7-3·75 μg/ml.) and of these 13 (87%) had associated CSF protein abnormalities and 9 (60%) were hypertensive. Mean serum FDP values were the same (4·4 μg/ml.) in patients with and without FDP in the CSF. Three patients had raised serum FDP concentrations but no FDP in the CSF. The evidence suggests that the presence of FDP in CSF indicates recent central nervous system damage. In this series the most common cause was vascular disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=494636Documentos Relacionados
- Fibrin-fibrinogen degradation products in cerebrospinal fluid.
- Serum fibrin/fibrinogen degradation products as a prognostic index in acute myocardial infarction.
- Letter: prognostic significance of serum levels of fibrin/fibrinogen degradation products and of myocardial enzymes in acute myocardial infarction.
- Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis.
- Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis
